|
Scales
|
Physical activity
|
Sedentary time
|
|---|
|
Mean (SD)
|
Adjusted mean difference of scores (95% CI)
|
Mean (SD)
|
Adjusted mean difference of scores (95% CI)
|
|---|
|
Low (n = 72)
|
Moderate (n = 140)
|
Pa
|
High (n = 252)
|
Pa
|
< 4 h/d (n = 246)
|
4–6 h/d (n = 152)
|
Pa
|
≥ 6 h/d (n = 66)
|
Pa
|
|---|
|
EORTC QLQ-C30
|
|
Physical function
|
78.63 ± 17.43
|
0.11(− 4.77, 4.56)
|
0.965
|
0.05(− 4.33, 4.43)
|
0.983
|
79.51 ± 15.40
|
− 1.82(− 4.85, 1.22)
|
0.241
|
− 3.75(− 10.64, 3.14)
|
0.285
|
|
Role function
|
91.40 ± 17.61
|
0.90(− 5.91, 4.12)
|
0.726
|
1.43(− 3.28, 6.13)
|
0.552
|
92.92 ± 16.93
|
− 1.83(− 5.12, 1.46)
|
0.275
|
− 1.89(− 9.45, 5.67)
|
0.623
|
|
Emotional function
|
82.76 ± 19.23
|
0.31(− 7.56, 2.94)
|
0.387
|
0.67(− 4.25, 5.60)
|
0.788
|
82.00 ± 17.71
|
− 0.12(− 3.60, 3.35)
|
0.944
|
0.48(− 7.51, 8.47)
|
0.906
|
|
Cognitive function
|
80.23 ± 17.31
|
− 2.99(− 8.94, 2.97)
|
0.325
|
− 3.87(− 9.46, 1.72)
|
0.174
|
76.88 ± 21.42
|
0.28(− 3.63, 4.19)
|
0.888
|
− 3.56(− 12.55, 5.42)
|
0.436
|
|
Social function
|
81.97 ± 20.24
|
− 4.53(− 11.51, 2.46)
|
0.203
|
− 4.06(− 10.62, 2.49)
|
0.224
|
78.66 ± 24.82
|
− 1.45(− 6.06, 3.17)
|
0.538
|
− 3.14(− 13.74, 7.47)
|
0.562
|
|
Global health/QoL
|
67.57 ± 24.09
|
− 1.15(− 7.91, 5.62)
|
0.739
|
− 0.32(− 6.67, 6.03)
|
0.920
|
68.28 ± 24.09
|
− 3.02(− 7.48, 1.44)
|
0.183
|
− 2.04(− 12.29, 8.21)
|
0.696
|
|
Fatigue
|
28.31 ± 20.64
|
0.79(− 5.35, 6.92)
|
0.801
|
0.92(− 4.84, 6.68)
|
0.753
|
29.94 ± 21.68
|
0.46(− 3.56, 4.48)
|
0.823
|
7.97(− 1.27, 17.21)
|
0.091
|
|
Nausea and vomiting
|
5.49 ± 13.02
|
− 2.51(− 5.46, 0.44)
|
0.096
|
− 1.96(− 4.73, 0.81)
|
0.164
|
2.77 ± 8.50
|
2.27(0.34, 4.21)
|
0.021
|
0.25(− 4.20, 4.69)
|
0.913
|
|
Pain
|
14.47 ± 18.74
|
7.18(1.12, 13.25)
|
0.020
|
4.31(− 1.39, 10.00)
|
0.138
|
18.60 ± 20.39
|
2.64(− 1.37, 6.65)
|
0.197
|
6.44(− 2.78, 15.65)
|
0.171
|
|
Dyspnoea
|
16.35 ± 20.65
|
4.78(− 1.80, 11.35)
|
0.154
|
1.91(− 4.26, 8.08)
|
0.544
|
19.32 ± 23.93
|
0.81(− 3.50, 5.13)
|
0.712
|
− 1.45(− 11.37, 8.46)
|
0.774
|
|
Insomnia
|
27.03 ± 26.79
|
2.96(− 5.53, 11.44)
|
0.494
|
0.86(− 7.11, 8.82)
|
0.833
|
28.24 ± 27.81
|
2.30(− 3.23, 7.84)
|
0.414
|
3.25(− 9.47, 15.98)
|
0.615
|
|
Appetite loss
|
8.66 ± 17.94
|
0.83(− 4.59, 6.25)
|
0.763
|
0.47(− 4.62, 5.56)
|
0.856
|
8.45 ± 16.67
|
2.22(− 1.32, 5.76)
|
0.218
|
− 0.27(− 8.40, 7.86)
|
0.948
|
|
Constipation
|
6.50 ± 15.75
|
6.01(0.01, 12.02)
|
0.050
|
6.45(0.81, 12.08)
|
0.025
|
9.94 ± 18.86
|
2.26(− 1.66, 6.18)
|
0.257
|
4.16(− 4.85, 13.16)
|
0.365
|
|
Diarrhea
|
12.12 ± 20.11
|
2.89(− 3.15, 8.93)
|
0.348
|
− 2.07(− 7.74, 3.60)
|
0.473
|
10.74 ± 18.32
|
2.75(− 1.21, 6.72)
|
0.173
|
2.20(− 6.91, 11.30)
|
0.636
|
|
Financial difficulties
|
28.01 ± 28.86
|
4.22(− 4.79, 13.23)
|
0.358
|
3.33(− 5.13, 11.00)
|
0.439
|
32.47 ± 31.37
|
5.64(− 0.30, 11.59)
|
0.063
|
− 2.74(− 16.41, 10.92)
|
0.693
|
- Italic face P < 0.05
- CS cancer survivor, CCD comorbid chronic disease
- aAdjusted for gender, age, BMI, education, marital status, household per capita income, time since diagnosis, recurrence, and metastasis
